scholarly journals Feasibility Study of a Randomised Trial of Ovarian Cancer Screening

1994 ◽  
Vol 1 (4) ◽  
pp. 215-219 ◽  
Author(s):  
Ann Tabor ◽  
Flemming R Jensen ◽  
Johannes E Bock ◽  
Claus K Høgdall

To assess the feasibility of a randomised trial of ovarian cancer screening by vaginal ultrasonography. A population based study, recruiting a random sample of the female population aged 46 to 65 years living in Copenhagen, Denmark. Randomised controlled trial allocating 50% to the study group having vaginal ultrasonography, and 50% to the control group having no examination, (a) Acceptability of the study was evaluated by the proportion of eligible women willing to participate in the study, (b) The false positive rate was evaluated as the proportion of women without ovarian cancer referred for an operation because of abnormal ovaries detected by ultrasonography. 950 (64–3%) of the 1477 eligible women participated in the study. At the first scan abnormal ovaries were detected in 54 of 435 women (12%), significantly more frequently among younger women. Nine women were referred for an operation because of abnormal findings in the ovaries, giving a false positive rate of 2%Ovarian size and morphology found at operation corresponded with those at ultrasonography; none of them was malignant. A randomised controlled trial of ovarian cancer screening using vaginal ultrasonography seems acceptable in the general population. The rate of abnormal ovaries at ultrasonography with the cut offs used in this study was quite high. Such a study is, therefore, feasible, but it is proposed that it is carried out in an older age group (50–64 years) and that the cut offs used for ovarian size and morphology are re-evaluated. Second line tests, such as colour Doppler flow, should be considered in order to reduce the false positive rate.

1994 ◽  
Vol 1 (4) ◽  
pp. 209-214 ◽  
Author(s):  
C A Parkes ◽  
D Smith ◽  
N J Wald ◽  
T H Bourne

To determine the feasibility of a randomised trial of ovarian cancer screening among women attending a breast cancer screening centre. Randomised controlled trial of ovarian cancer screening using transvaginal ultrasonography as a primary screening test and colour Doppler imaging as a secondary screening test in the screened group and no intervention in the control group. Reading breast cancer screening centre (United Kingdom). 8678 women, without a bilateral oophorectomy or hysterectomy, aged between SO and 64 attending for NHS breast cancer screening between September 1989 and February 1993. Uptake of ovarian cancer screening among eligible women and the screening false positive rate (considered as the referral rate to a gynaecologist for surgical intervention). −82% (7124/8678) of eligible women agreed to join the trial and were randomly allocated in equal numbers to each arm of the trial. 3280 women had an initial scan. The false positive rate after ultrasonography alone was 2·9% (86/2952), but this dropped to 0·5% after colour Doppler as a secondary screening test. One stage I primary ovarian cancer was detected at screening in a 58 year old women. A randomised trial of ovarian cancer screening using ultrasonography and colour Doppler imaging is feasible and acceptable among women attending a breast cancer screening centre. The results indicate that the expected odds of being affected given a positive result in the general population would be about 1:12. A full randomised trial of ovarian cancer screening with mortality as the end point is needed to assess whether screening reduces mortality from this disease. A multicentre European trial is currently in progress.


The Lancet ◽  
2016 ◽  
Vol 387 (10022) ◽  
pp. 945-956 ◽  
Author(s):  
Ian J Jacobs ◽  
Usha Menon ◽  
Andy Ryan ◽  
Aleksandra Gentry-Maharaj ◽  
Matthew Burnell ◽  
...  

1994 ◽  
Vol 10 (1) ◽  
pp. 33-40 ◽  
Author(s):  
Jane Wardle ◽  
Amanda Pernet ◽  
William Collins ◽  
Thomas Bourne

Sign in / Sign up

Export Citation Format

Share Document